X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs PANACEA BIOTECH - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA PANACEA BIOTECH FULFORD INDIA/
PANACEA BIOTECH
 
P/E (TTM) x 398.8 81.4 489.8% View Chart
P/BV x 6.2 1.8 343.7% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FULFORD INDIA   PANACEA BIOTECH
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
PANACEA BIOTECH
Mar-14
FULFORD INDIA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs942149 633.5%   
Low Rs45082 546.8%   
Sales per share (Unadj.) Rs691.484.1 821.7%  
Earnings per share (Unadj.) Rs11.5-18.3 -62.6%  
Cash flow per share (Unadj.) Rs15.4-6.7 -229.3%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.083.7 454.0%  
Shares outstanding (eoy) m3.9061.25 6.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.4 73.3%   
Avg P/E ratio x60.7-6.3 -962.5%  
P/CF ratio (eoy) x45.3-17.2 -262.8%  
Price / Book Value ratio x1.81.4 132.7%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7147,074 38.4%   
No. of employees `0000.42.8 16.1%   
Total wages/salary Rs m5051,449 34.8%   
Avg. sales/employee Rs Th6,073.01,874.1 324.1%   
Avg. wages/employee Rs Th1,137.4527.0 215.8%   
Avg. net profit/employee Rs Th100.7-407.7 -24.7%   
INCOME DATA
Net Sales Rs m2,6965,154 52.3%  
Other income Rs m125100 125.7%   
Total revenues Rs m2,8225,254 53.7%   
Gross profit Rs m-46-766 6.1%  
Depreciation Rs m15711 2.1%   
Interest Rs m101,503 0.6%   
Profit before tax Rs m54-2,881 -1.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m1017 57.1%   
Profit after tax Rs m45-1,121 -4.0%  
Gross profit margin %-1.7-14.9 11.6%  
Effective tax rate %17.7-0.6 -3,031.3%   
Net profit margin %1.7-21.8 -7.6%  
BALANCE SHEET DATA
Current assets Rs m1,7383,810 45.6%   
Current liabilities Rs m5458,365 6.5%   
Net working cap to sales %44.3-88.4 -50.1%  
Current ratio x3.20.5 700.6%  
Inventory Days Days48156 31.1%  
Debtors Days Days467 6.4%  
Net fixed assets Rs m1214,480 0.1%   
Share capital Rs m3961 63.6%   
"Free" reserves Rs m1,443903 159.8%   
Net worth Rs m1,4825,127 28.9%   
Long term debt Rs m05,832 0.0%   
Total assets Rs m2,07719,433 10.7%  
Interest coverage x6.7-0.9 -732.8%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.30.3 489.6%   
Return on assets %2.62.0 132.9%  
Return on equity %3.0-21.9 -13.8%  
Return on capital %4.33.6 118.4%  
Exports to sales %024.5 0.0%   
Imports to sales %24.510.2 240.1%   
Exports (fob) Rs mNA1,264 0.0%   
Imports (cif) Rs m659525 125.6%   
Fx inflow Rs m171,539 1.1%   
Fx outflow Rs m673942 71.5%   
Net fx Rs m-656597 -109.8%   
CASH FLOW
From Operations Rs m90599 15.0%  
From Investments Rs m105-438 -23.9%  
From Financial Activity Rs m-14-303 4.7%  
Net Cashflow Rs m181-141 -127.7%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 0.6 633.3%  
FIIs % 0.1 1.3 7.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 23.6 89.8%  
Shareholders   4,783 10,259 46.6%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  FDC LTD.  ORCHID PHARMA LTD  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS